Navigation Links
20th ECNP Congress 2007, Oct. 13-17, Vienna, Austria
Date:10/4/2007

rs of the brain. The ECNP Congress is also expected to raise awareness about the size and burden of mental disorders in Europe and the availability of new treatments and to stimulate discussion about ways of implementing new knowledge and new therapeutic approaches.

The ECNP Congresses, playing a leading role in bringing together distinguished scientists identifying and testing promising new medications with novel mechanisms, are currently paving the groundwork for the next generation of pharmacological treatments, which will improve the lives of the millions of people who suffer from mental disorders.

Outstanding Highlights of the 20th ECNP Congress

Among the ECNP Congress extensive programmatic coverage of over 100 topics presented by over 600 experts, this years outstanding highlights are:

  • Latest research in Alzheimer's disease opens the door for new treatments: Groundbreaking new discoveries have opened the door for a new and better understanding of Alzheimers disease, as one of the most important future public health challenges. This work presented by Thomas Bayer carries the promise of developing new treatments.

  • Neurobiological pathways between depression and cardiovascular diseases are clarified: Latest research is now available that helps us to understand which common biological changes are involved in the already known link between depression and life-threatening cardiovascular disease. Alexander Glassman will present and discuss the therapeutic consequences of these findings.

  • Genetic contributions to human brain morphology and intelligence: Hilleke Hulshoff Pol presents persuasive evidence how genetic factors influence the brain structure opening new insights into the reciprocal gene-environment developmental pathways.

  • The role and therapeutic opportunities of cannabinoids: Raphael Mechoulam also last year winner of
    '/>"/>

Contact: Sonja Mak
s.mak@update.europe.at
43-140-557-3413
European College of Neuropsychopharmacology
Source:Eurekalert

Page: 1 2 3 4

Related biology news :

1. New results validating Pall prion reduction filter disclosed at ISBT Congress
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... , Dec. 16, 2014  Automation is ... this more evident than at international borders. Over ... document scanners have allowed veteran travelers to self ... Passport Control (APC) Kiosks at an increasing number ... globe. According to Maxine ...
(Date:12/11/2014)... Dec. 10, 2014  Data Sciences International (DSI), ... released a new series of digital telemetry implants ... researchers. M series, part of the PhysioTel™ Digital ... best possible physiologic data when incorporating functional endpoints ... endpoints to toxicology studies has evolved from short ...
(Date:12/10/2014)... 2014 Research and Markets ( ... "Biometrics Market in Japan 2014-2018" report ... http://photos.prnewswire.com/prnh/20130307/600769 The integration of biometrics ... banking and upgradation of the driver,s license is ... market. Besides the aforementioned projects, biometrics is being ...
Breaking Biology News(10 mins):Automated Border Control (ABC) Transforms the Global Travel Experience With More Than 2500 ABC eGates and APC Kiosks Deployed In Airports, Seaports, and Land Borders Worldwide 2New telemetry implants expected to change how large animal toxicology studies are conducted 2Biometrics Market in Japan 2014-2018: Key Vendors are DDS, Fujitsu, Hitachi and NEC 2
... The Yam bean originated where the Andes meet the Amazon ... Asia, East Asia and the Pacific. It is produced in ... Interbreeding of the bean has resulted in fertile and stable ... single species, provide high quality food production and offer a ...
... Agricultural Biotechnology: Economics and Policy, edited by ... Zilberman, has won the Quality of Communication Award ... Award recognizes publications that demonstrate superior communication of ... Regulating Agricultural Biotechnology: Economics and Policy assembles ...
... named as the 2007 winner of the ALPSP/Charlesworth Award ... recognises a significantly innovative approach to any aspect of ... this years award was RSC Project Prospect from the ... of semantics into chemical science publishing. RSC Project Prospect ...
Cached Biology News:Yam bean a nearly forgotten crop 2RSC Project Prospect scoops prestigious award 2
(Date:12/17/2014)... 2014 Achim Noack has been named ... Group. In this position, Noack will assist Jerry Stoller, ... develop marketing strategy and supervise global marketing management and ... has tremendous knowledge and experience in the crop protection ... experience and innovative thinking will be a great asset ...
(Date:12/17/2014)... Park, CA (PRWEB) December 17, 2014 ... announces today that it has entered into a ... Midland Company (ADM) to apply DNA2.0’s proprietary protein ... enzyme engineering process. , “We are extremely excited ... ProteinGPS engineering platform. This proprietary bioengineering technology ...
(Date:12/17/2014)... , Dec. 17, 2014 Tigercat Pharma, ... 2 study evaluating the investigational oral NK-1 receptor ... with severe, chronic itch who are unresponsive or ... including topical steroids and antihistamines. ... Visual Analog Scale (VAS) itch score from baseline, ...
(Date:12/15/2014)... NEW YORK , Dec. 15, 2014  GlassesOff ... Yuval Bar-Gil as an independent director of ... was founder of AeroScout and served as its CEO ... Decker in 2012, a $240 million transaction. Recognized as ... under Mr. Bar-Gil,s leadership, AeroScout provided Wi-Fi -based RFID ...
Breaking Biology Technology:Achim Noack Joins Stoller Group as Global Vice President of Marketing and Administration 2ADM and DNA2.0 Enter Into Protein Engineering Technology Access and Service Agreement 2Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 2Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 3Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 4AeroScout Founder Joins GlassesOff's Board of Directors 2AeroScout Founder Joins GlassesOff's Board of Directors 3
... ST. PAUL, Minn., Jan. 3 /Xinhua-PRNewswire/ --,WuXi ... provider of pharmaceutical R&D,outsourcing services, has signed ... Services, Inc. (AppTec). The acquisition of AppTec ... and expertise,gain a significant U.S. operational footprint, ...
... Pharmos Corporation,(Nasdaq: PARS ) announced today ... private placement of its 10% Convertible Debentures due ... $4,000,000 principal amount of the,Debentures, at par, and ... The purchasers consisted of certain existing investors in ...
... Jan. 3 TAP Pharmaceutical Products,Inc. today announced the ... Food and Drug Administration (FDA) for the use of ... and maintenance of,patients with erosive esophagitis and non-erosive reflux ... novel delivery system., "This compound and its novel ...
Cached Biology Technology:WuXi PharmaTech to Acquire AppTec Laboratory Services, Inc. 2WuXi PharmaTech to Acquire AppTec Laboratory Services, Inc. 3WuXi PharmaTech to Acquire AppTec Laboratory Services, Inc. 4WuXi PharmaTech to Acquire AppTec Laboratory Services, Inc. 5Pharmos Corporation Completes Initial Closing of Private Placement 2